Articles From: Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock to Forest Laboratories names Alex Kelly Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations


Forest Laboratories, Inc. (NYSE: FRX) today announced a series of significant strategic actions to streamline operations and reduce costs, leverage the Company’s balance sheet by issuing new debt, and return cash to shareholders through a new share repurchase authorization and an accelerated share repurchase program.
Sign-up for Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock investment picks
Forest Laboratories, Inc. (NYSE:FRX) announced today that FETZIMA ™ (levomilnacipran ER capsules), is now available in pharmacies throughout the United States.
Sign-up for Forest Announces New FETZIMA™ (levomilnacipran ER capsules) Now Available in Pharmacies Throughout U.S. investment picks
CLEVELAND , BROOKLYN, N.Y. and SHANGHAI , Dec.
Sign-up for Forest City and Greenland Group Sign Definitive Agreement for Joint Venture at Atlantic Yards in Brooklyn investment picks
2013/10/11
CLEVELAND , BROOKLYN , N.Y. and SHANGHAI , Oct.
Sign-up for Forest City and Greenland Group Sign Memorandum of Understanding to Form Joint Venture for Atlantic Yards in Brooklyn investment picks
CLEVELAND , Sept.
Sign-up for Forest City Announces Redemption of 7.375% Senior Notes Due 2034 investment picks
2013/10/21
CLEVELAND , Oct.
Sign-up for Forest City Announces Redemption of Remaining 3.625% Puttable Equity-Linked Notes due 2014 investment picks
2014/3/27
Sale generates proceeds of approximately $21.5 million CLEVELAND , March 27, 2014 /PRNewswire/ -- Forest City Enterprises, Inc., (NYSE: FCEA and FCEB) today announced that it has closed the sale of Quartermaster Plaza, a 456,000-square-foot, grocery-anchored specialty retail center in Philadelphia , to Cedar Realty Trust, Inc.  The sale price was $92.3 million , representing a cap rate of approximately 6.5 percent based on projected 2014 net operating income.
Sign-up for Forest City completes disposition of Philadelphia retail center investment picks
2014/1/8
- Four, fourth-quarter sales generate approximately $133 million in cash proceeds - Company generated $600 million in 2013 from dispositions and QIC strategic partnership; majority of proceeds go to debt reduction CLEVELAND , Jan.
Sign-up for Forest City completes final asset dispositions of 2013 investment picks
Disposition generates approximately $39 million in net cash proceeds CLEVELAND , Aug.
Sign-up for Forest City completes sale of Higbee Building in Cleveland investment picks
Disposition generates approximately $30 million in net cash proceeds to Forest City CLEVELAND , Aug.
Sign-up for Forest City completes sale of Liberty Center complex in Pittsburgh investment picks
ServiceNow (NYSE: NOW), the enterprise IT cloud company, today announced that Forest City Enterprises has implemented ServiceNow software-as-a-service platform and ServiceNow IT Service Automation Suite to consolidate IT systems, offer employees self-service functionality and automate business processes within and beyond IT.
Sign-up for Forest City Enterprises Deploys ServiceNow to Automate Business Services investment picks
2013/8/30
CLEVELAND , Aug.
Sign-up for Forest City Enterprises Notice of Second-Quarter 2013 Earnings and Conference Call investment picks
2014/2/21
CLEVELAND , Feb.
Sign-up for Forest City Enterprises Notice of Yearend 2013 Earnings and Conference Call investment picks
Boingo Wireless (NASDAQ: WIFI) , the leading DAS and Wi-Fi provider that serves consumers, carriers and advertisers worldwide, today announced a new agreement with Forest City Ratner Companies (FCRC) to provide free-to-shopper Wi-Fi at the company’s high-traffic shopping center in Brooklyn, the Atlantic Terminal Mall, which serves more than 40 million shoppers and commuters annually.
Sign-up for Forest City Ratner Selects Boingo for Retail Wi-Fi Deployment investment picks
Report based on Global Reporting Initiative guidelines CLEVELAND , Aug.
Sign-up for Forest City releases its first Corporate Social Responsibility report investment picks
- Results reflect impact of smaller under-construction pipeline, reduced capitalized interest - Continued progress on sustainable capital, non-core dispositions, focused growth - Operating portfolio shows solid fundamentals CLEVELAND , Sept.
Sign-up for Forest City Reports Fiscal 2013 Second-Quarter and Year-to-Date Results investment picks
2013/12/9
-- Company continues strategic transformation with core-market focus, deleveraging --
Sign-up for Forest City Reports Fiscal 2013 Third-Quarter and Year-to-Date Results investment picks
2014/2/27
"Year of transformation:" - total debt reduced by $1.1 billion - strategic partnership formed with QIC for eight regional malls - definitive agreement signed with Greenland Group for Atlantic Yards - residential development activated through ASRS fund - 10 dispositions generated approximately $250 million total cash proceeds Company completes transition to calendar-year reporting 2013 non-cash impairments of $339.8 million (pre-tax, at pro-rata) at Atlantic Yards and Las Vegas land CLEVELAND , Feb.
Sign-up for Forest City Reports Results for 11 Months Ended December 31, 2013 investment picks
2014/2/28
CLEVELAND , Feb.
Sign-up for Forest City to present at Citi 2014 Global Property CEO Conference investment picks
- JVs expected to generate approximately $350 million in liquidity for Forest City CLEVELAND , Sept.
Sign-up for Forest City, QIC complete joint ventures for portfolio of retail malls investment picks
2014/3/4
Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, and Adamas Pharmaceuticals Inc., a privately held specialty pharmaceutical company, announced Forest’s submission of a New Drug Application (NDA) to the Food and Drug Administration for a fixed-dose combination (FDC) of memantine HCl extended release (ER) and donepezil HCl for the treatment of moderate to severe dementia of the Alzheimer’s type.
Sign-up for Forest Laboratories and Adamas Pharmaceuticals Announce Forest’s Submission of New Drug Application for Memantine Extended Release and Donepezil Fixed-Dose Combination for Alzheimer’s Disease investment picks
2013/8/14
Forest Laboratories, Inc. (NYSE: FRX) and Almirall, S.A. (ALM:MC) today announced that they will delay the planned Q4 2013 submission of a New Drug Application (NDA) for the combination of aclidinium bromide, a long acting muscarinic antagonist and formoterol fumarate, a long acting beta agonist, for the indication of Chronic Obstructive Pulmonary Disease (COPD). This decision was based on comments provided by the FDA at a recent pre-NDA meeting.
Sign-up for Forest Laboratories and Almirall Decide to Delay NDA Filing for Aclidinium/formoterol Combination investment picks
2014/4/9
Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) today announced that they have recently received feedback from the U.S. Food and Drug Administration (FDA) regarding the fixed dose combination of aclidinium and formoterol.
Sign-up for Forest Laboratories and Almirall Provide Update on the Fixed Dose Combination of Aclidinium and Formoterol in the U.S. investment picks
2013/11/21
Forest Laboratories, Inc. (NYSE:FRX) and Gedeon Richter Plc.
Sign-up for Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine investment picks
Forest Laboratories, Inc. (NYSE:FRX) today announced appointments to its executive leadership team.
Sign-up for Forest Laboratories Announces Appointments to its Executive Team investment picks
Forest Laboratories, Inc. (NYSE:FRX) today announced that Robert Bailey was appointed Senior Vice President, Chief Legal Officer General Counsel.
Sign-up for Forest Laboratories Names A. Robert D. Bailey Senior Vice President, Chief Legal Officer and General Counsel investment picks
Forest Laboratories, Inc. (NYSE:FRX) today announced that Alex Kelly has been named Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations.
Sign-up for Forest Laboratories names Alex Kelly Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock to Forest Laboratories names Alex Kelly Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity